Market revenue in 2020 | USD 159.1 million |
Market revenue in 2028 | USD 309.2 million |
Growth rate | 8.7% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Software & Services |
Key market players worldwide | Diasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 65.93% in 2020. Horizon Databook has segmented the Brazil chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
Brazil is anticipated to be the most lucrative market for CLIA products in Latin America. This dominance can be attributed to the presence of established healthcare infrastructure and favorable healthcare reimbursement scenario as compared to other Latin American countries.
Furthermore, increasing entry of key players in the Brazilian market is anticipated to support the market growth in the country over the forecast period. For instance, in September 2019, UK-based Erba Mannheim established its new subsidiary in Nova Lima, Brazil.
Through this new subsidiary, the company started marketing full range of its CLIA, clinical chemistry, hematology, and urinalysis products in the Brazilian market. In addition, ongoing regulatory approvals for novel CLIA solutions in the country are expected to fuel the market growth in Brazil.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil chemiluminescence immunoassay market , including forecasts for subscribers. This country databook contains high-level insights into Brazil chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account